$サイト・サイエンシズ(SGHT.US)$ NEWS Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma Sight Sciences, Inc. (Nasdaq: SGHT) announces results of a large-scale MIGS study comparing three leading technologies in glaucoma patients. OMNI technology shows significant IOP and...
Revolutionizing Glaucoma and Dry Eye Treatment: Insights from Sight Sciences' Groundbreaking Clinical Trials. In the realm of ophthalmology, groundbreaking advancements are not just welcomed; they are necessary. As we navigate through the complexities of eye diseases, companies like Sight Sciences are leading the charge with innovative solutions that promise not only relief but also a renewed hope for millions globally. Rec...
Sight Sciences' high P/S ratio may be precarious given forecasted revenue declines, posing the risk of a future drop in share prices despite recent gains.
Post downgrade, analysts are skeptical about Sight Sciences' value. 2024 revenue drop hints at measured investor expectations. Due to recent business events, a slashed price target may steer investors towards caution.
Pre-Market Stock Movers Gapping up $アップル(AAPL.US)$stock rose 0.2% ahead of the iPhone maker's latest hardware update in California later in the session, which is expected to see the launch of the iPhone 15. $ボーイング(BA.US)$stock rose 0.1% after SMBC Aviation Capital, the world's second largest aircraft leasing firm, said it had concluded an order for 25 Boeing 737 MAX aircraft in a deal worth more than $3.7 billion a...
サイト・サイエンシズに関するコメント
NEWS
Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma
Sight Sciences, Inc. (Nasdaq: SGHT) announces results of a large-scale MIGS study comparing three leading technologies in glaucoma patients. OMNI technology shows significant IOP and...
Ophthalmology Company Reports Promising Dry Eye Disease Treatment Results
In the realm of ophthalmology, groundbreaking advancements are not just welcomed; they are necessary. As we navigate through the complexities of eye diseases, companies like Sight Sciences are leading the charge with innovative solutions that promise not only relief but also a renewed hope for millions globally. Rec...
コラムToday's Pre-Market Stock Movers and Top Ratings: ORCL, UPS, RTX, WRK and More
Gapping up
$アップル(AAPL.US)$ stock rose 0.2% ahead of the iPhone maker's latest hardware update in California later in the session, which is expected to see the launch of the iPhone 15.
$ボーイング(BA.US)$ stock rose 0.1% after SMBC Aviation Capital, the world's second largest aircraft leasing firm, said it had concluded an order for 25 Boeing 737 MAX aircraft in a deal worth more than $3.7 billion a...
Halt down
コラムIPO Buzz: Shopping center REIT PECO leads a 15-deal week
まだコメントはありません